John Montana

John Montana is an experienced leader in the life sciences sector with a robust background in project management and operations. Currently serving as an Advisory Board Member at Arpeggio Biosciences since August 2024 and as a Deal Lead with NuFund Venture Group since January 2024, John contributes to innovative biotech solutions and emerging technology investments. With previous roles including Principal at JPM Development Consulting and Chief Operating Officer at Aristea Therapeutics, John has cultivated expertise in managing R&D activities and optimizing resource efficiency. Furthermore, John held senior positions at Ardea Biosciences, Genoptix, Anadys Pharmaceuticals, Pfizer, and Agouron Pharmaceuticals, where responsibilities ranged from establishing project management structures to executing local development portfolios. John commenced a career in research at Genetic Systems Corp and holds a Bachelor of Science in Microbiology/Immunology from the University of Washington.